Kansas House Bill HB2353

Kansas 2025-2026 Regular Session

• Introduced: 2/7/25
• Refer: 2/7/25

Caption

Requiring that certain written information be provided to patients when a physician or healthcare provider administers or prescribes any medicine or drug for the purpose of inducing an abortion.

Summary

HB2353 would require physicians and other healthcare providers in Kansas to give patients a specific written notice whenever they prescribe, dispense, or administer a drug or medicine for the purpose of inducing an abortion. The notice is framed as a warning that patients and their families may hold the manufacturer, distributor, physician, or provider financially accountable if the patient dies, is injured, experiences complications or side effects, the medication fails, or the provider does not address side effects. It also tells patients that if they need emergency care after taking abortion-inducing medication, they may disclose that fact to the treating provider without criminal or civil penalty. The bill defines “abortion” and “physician” by reference to existing Kansas law and would take effect upon publication in the statute book. In practical terms, it adds a mandatory disclosure requirement to medication abortion care and creates a state-required script that providers must deliver in writing before dispensing abortion-inducing medication.

Impact

HB2353 would amend Kansas health-care practice by imposing a new patient-notice obligation on physicians and healthcare providers involved in medication abortions. It does not directly change the legality of abortion itself, but it would regulate the information that must be provided to patients and could affect clinical counseling, documentation practices, and provider liability discussions. The bill references existing abortion definitions in K.S.A. 65-6701, tying the new requirement into Kansas abortion law and potentially affecting providers, patients, manufacturers, and distributors involved in abortion-inducing drugs.

Sentiment

Based on the bill’s sponsorship and framing, the measure appears strongly supported by anti-abortion advocates and introduced at the request of Kansans for Life. The text emphasizes patient warning, accountability, and emergency disclosure, suggesting the bill is intended to discourage or further regulate medication abortion rather than expand access. No committee debate or recorded votes were provided, so there is no direct evidence of broader legislative sentiment in the available materials beyond the bill’s pro-life orientation.

Contention

The main point of contention is likely to be whether the required notice is a neutral informed-consent measure or a politically motivated warning that could mislead patients about medication abortion risks and legal rights. Supporters would likely argue that patients should be informed about possible complications and accountability options, while opponents may view the language as stigmatizing abortion care, pressuring patients, and imposing a state-scripted message on medical providers. The requirement to tell patients they may hold multiple parties financially accountable, and the emphasis on emergency disclosure, are likely to be especially controversial among abortion-rights advocates and healthcare providers.